Please use this identifier to cite or link to this item:
|Title:||EFFECTS OF INTERFERON TREATMENT ON HBV PRE-CORE MUTANTS IN CHRONIC HEPATITIS B CARRIERS IN SINGAPORE||Authors:||LIAU LIAN SOON||Keywords:||Hepatitis B virus Singapore Effects of drugs on||Issue Date:||1996||Citation:||LIAU LIAN SOON (1996). EFFECTS OF INTERFERON TREATMENT ON HBV PRE-CORE MUTANTS IN CHRONIC HEPATITIS B CARRIERS IN SINGAPORE. ScholarBank@NUS Repository.||Abstract:||The significance of the different hepatitis B virus (HBV) pre-core variants and their relationship to interferon treatment in chronic hepatitis B carriers were investigated. Ten chronic hepatitis B carriers (8 male, 2 female; age range 28-53yrs; 6 chronic active hepatitis (CAH), 4 chronic persistent hepatitis (CPH)) were given beta-interferon subcutaneously for 24 weeks. Eight other patients (5 male, 3 female; age range 24-58yrs; 4 CAH, 4 CPH) acted as controls. Patients are Chinese except one. Nine of the 10 treated patients had positive response with lowering of HBV DNA, ALT and AST levels while on interferon. Four CAH patients (66. 7%) and I CPH patient (25%) showed persistent loss of HBV DNA by blot hybridisation during follow-up after treatment. The common pre-core mutants found were stop codon mutant at codon 28 (nucleotide substitution from 'G' to 'A' at 1896), missense mutant at codon 15 (C' to 'T' at 1856), missense mutant at codon 29 ('G' to A' at 1899) with C28 stop codon mutation, and missense mutant at codon 29 ('G' to 'A' at 1898) with C15 mutation. Most carriers were found to harbour mix pre-core isolates of HBV. These mutants appear to occur randomly. C28 mutants were frequently found in CAH patients (5 of 10). CAH patients responded better than CPH patients to interferon treatment while the treatment had no selective effects upon the HBV mutants.||URI:||https://scholarbank.nus.edu.sg/handle/10635/153212|
|Appears in Collections:||Master's Theses (Restricted)|
Show full item record
Files in This Item:
|b19893966.pdf||2.83 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.